Ibex Investors’s Chemours CC Stock Holding History

Ibex Investors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,188	Closed	-$184K	–	27
2019 Q4	$184K	Sell	10,188 -2,161	-17%	-$35.9K	﹤0.01%	40
2019 Q3	$184K	Buy	+12,349	New	+$201K	0.01%	38

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ibex Investors's CC Position: Q1 2020 in Review

Ibex Investors sold out of Chemours (CC) in Q1 2020, closing a stake of 10,188 shares — an estimated $184K sold.

Ibex Investors first reported a position in CC in Q3 2019 and held it in 2 quarters. The position peaked at $184K in Q4 2019. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

Ibex Investors reported no remaining Chemours position as of Q1 2020 after selling out during the quarter.
Ibex Investors sold 10,188 Chemours shares in Q1 2020, an estimated $184K.
Ibex Investors first reported a position in Chemours in Q3 2019 and held it in 2 quarters.
Ibex Investors's Chemours position peaked at $184K in Q4 2019.
416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Ibex Investors's 13F filing for Q1 2020, filed 14 May 2020.